We found for
Value, Access, and Incentives for Innovation: Policy Perspectives on Alternative Models for Pharmaceutical Rebates
![Value, Access, and Incentives for Innovation - Policy Perspectives on Alternative Models for Pharmaceutical Rebates](https://www.ohe.org/wp-content/uploads/2019/03/Value-Access-and-Incentives-for-Innovation-Policy-Perspectives-on-Alternative-Models-for-Pharmaceutical-Rebates.jpg)
Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England
![Front Cover (V2)](https://www.ohe.org/wp-content/uploads/2019/07/Front-Cover-V2_0.jpg)
Issues Surrounding the Estimation of the Opportunity Cost of Adopting a New Health Care Technology: Areas for Further Research
![Issues Surrounding the Estimation of the Opportunity Image](https://www.ohe.org/wp-content/uploads/2018/08/Issues-Surrounding-the-Estimation-of-the-Opportunity-Image_0.jpg)
A Critique of the Paper “The Estimated Costs of Production and Potential Prices for the World Health Organization Essential Medicines List”
![Image Critique Hill](https://www.ohe.org/wp-content/uploads/2018/05/Image-Critique-Hill.gif)
Understanding the Context, Selecting the Standards: A Framework to Guide the Optimal Development and Use of Real-World Evidence for Coverage and Formulary Decisions
![Understanding the Context Cover Page](https://www.ohe.org/wp-content/uploads/2018/04/Understanding-the-Context-Cover-Page_1.jpg)